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Abstract
Background:  This study has evaluated urinary tract injuries and dysfunction after Radical
Hysterectomy (RH) performed in patients with cervical cancer and has compared the cystometric
parameters and urinary complications occurring in these patients with those occurring in patients
who had undergone Simple Hysterectomy (SH).
Patients and methods: A prospective case-control study was conducted to evaluate urinary
tract injuries (intra-operative and post-operative) and dysfunction in 50 patients undergoing RH for
cervical cancer and to compare them with the same parameters in 50 patients who underwent SH
for benign disease.
Results: Mean age in the RH group was 46.3 years and in the SH group was 50.1 (p = 0.63). There
were no bladder and urethral injuries in either group of patients. There was one intra-operative
ureteral injury in the RH patients but none in those who underwent SH. (p < 0.05). In the two
weeks after surgery, 15% of RH patients and 11% of SH patients had experienced a urinary tract
infection urinary tract infection (p = 0.61). Two week after surgery 62% of RH patients had no
urinary symptoms, compared to 84% in the SH group who did (p < 0.02). Urinary residual volume,
first urinary sensation and maximal bladder capacity were higher in the RH group, but this was not
statistically significant. The only case of a urinary fistula appeared in a patient who received 5000
cGy radiation therapy pre-operatively, but this spontaneously healed after 3 weeks of
catheterization.
Conclusions: Intra-operative and post-operative urinary tract complications are comparable in
patients undergoing RH and SH and an expert gynaecological oncologist might be able to further
decrease complications. However, radiation therapy before surgery may increase the risk of
complications.
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Background
Although the incidence of lower urinary tract complica-
tions after RH has been reported with variable rates, up to
one half of patients undergoing RH experience at least one
lower urinary tract symptom that develops after surgery
and at a variable period of time [1,2]. Several retrospective
studies have examined lower urinary tract dysfunction
and traumatic injuries in patients who have undergone
RH [3,4].
In this study, we prospectively evaluated intra-operative
urinary tract injuries in addition to post-operative urinary
tract dysfunction and infection at 2, 6, and 14 weeks fol-
lowing surgery. We also compared these findings with
those at the same times in patients who underwent SH for
benign disease.
Patients and methods
Between October 2000 and December 2002, 50 women
who underwent RH and bilateral lymph node dissection
(BLND) were considered eligible for inclusion in the
study. All patients had squamous cell carcinoma of cervix
(SCC Cx.) and were staged as being Stages I and II. The
operations were performed by the same gynaecological
surgeons, using the same standard technique (class III
Piver & Rutledge). Pre-operative management was stand-
ardised for all patients. Preoperatively a detailed medical
history, physical examination, routine laboratory tests,
pelvic CT-scan (with intravenous and oral contrast), urine
analysis, and urine culture were carried out.
The exclusion criteria were; a history of voiding dysfunc-
tion, previous pelvic surgery, brain or spinal cord diseases,
diabetes mellitus, and contraindications to urodynamic
studies. The latter included a history of vesicoureteral
reflux, hydronephrosis, frequent or recent urinary tract
infection or urethral stricture. Patients received one pre-
operative and three post-operative doses of a second gen-
eration cephalosporin (Cephazolin).
The duration of surgery, amount of intra-operative haem-
orrhage and the occurrence of any organ injuries were
recorded. A Foley's catheter was inserted at the time of sur-
gery and was left in place for two weeks after surgery. The
patient's urinary catheter was removed when their post-
voiding residual volume was less than 75 ml.
Water cystometry, urinalysis and urine culture were per-
formed at 2, 6, 14 weeks after operation. The test for water
cystometry was performed with the subject lying in a
supine position. A 12F double-lumen catheter was intro-
duced transurethrally into the bladder to withdraw resid-
ual urine. The pressure-volume relationship of the
bladder was determined by filling the bladder with isot-
onic saline at a rate of 30–50 ml/min. The cystometry fill
phase ceased when the patient experienced an urge to void
urine, the first indication being leakage through the ure-
thra, or a bladder volume of 600 ml (which ever occurred
first). The volume at the termination of the fill-phase was
designated as the maximum bladder capacity (MBC). We
also assessed the bladder volume of each patient at their
first desire to void (V desire, ml). Post-void residual urine
volume (RU) was determined by transurethral catheteri-
zation after voiding had ceased. The presence or absence
of any urinary symptoms was determined by both ques-
tionnaire and direct interview with the patient.
Fifty patients with benign disease who had underwent SH,
were evaluated at the same time periods in the same way
for comparison with the RH group of patients. In the SH
group of patients, the Foley's catheter was inserted for 24
hours after operation. Data were analysed by SPSS statisti-
cal software using the chi-square and Student's 't' test for
data analysis.
Results
During this study, 50 patients with early stage cervical can-
cer and who underwent RH for cervical cancer and 50
patients who had undergone SH for benign disease were
evaluated. Two patients in the RH group and 3 from the
SH group were lost during the study. The mean ages and
their BMIs (Body Mass Index) in two groups of patients
were not statistically different. However, parity in the RH
group was higher (p < 0.05) (Table 1). In the RH group,
the stages for the cervical cancer were 65.1%, 23.2% and
11.6% for I, IIA and IIB stages, respectively. Patients who
had stage IB2 or higher stages of cervical cancer received
4500–5000 cGy of irradiation pre-operatively. None of
these patients received adjuvant radiation during the
interval between surgery and performance of urodynamic
studies.
In the SH group, the most common pathological condi-
tions requiring hysterectomy were as follows; dysfunc-
tional uterine bleeding (47.83%), uterine myoma
(21.7%), ovarian cyst (10.8%), chronic pelvic pain
(4.3%), adenomyosis (4.3%), endometrial cancer
(4.35%), CIN (4.35%) and molar pregnancy (2.17%).
The average blood loss and mean operative time for both
groups are shown in table 1. There were no bladder and
urethral injuries occurring during the primary operation
in either of the two groups of patients. One patient (with
stage Ib1 cervical cancer) in the RH group had an intra-
operative ureteral injury (which happened at the time of
"unroofing" the distal part), and the ureteral anastomosis
was carried out at that time. The urinary catheter and ure-
teral stent were removed four weeks after operation.World Journal of Surgical Oncology 2005, 3:12 http://www.wjso.com/content/3/1/12
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Another patient (with stage Ib2  cervical cancer) had
received chemo-irradiation (5000 cGy) pre-operatively.
She had a spontaneous urine leakage from the vagina
approximately 2 months after surgery. A retrograde
cystography revealed a minute vesico-vaginal fistula. After
3 weeks of continuous bladder drainage, the fistula
resolved spontaneously and she had no urinary leakage at
her follow-up visits.
Post-operative positive urine culture and urinary symp-
toms (dysuria, frequency, nocturia and dribbling) are
showed in table 2. Urinary symptoms occurred more
commonly in patients who had undergone pre-operative
radiotherapy, but this difference was not statistically sig-
nificant (table 3). The abnormal findings as regards water
cystometry are shown in table 4.
Discussion
Modern surgical techniques have resulted in a decrease in
the incidence of lower urinary tract complications occur-
ring as a result of radical hysterectomy. In particular, in
recent times, various surgical strategies have been devel-
oped to avoid damaging the inferior segment of the
cardinal ligament as well as the terminal bundle in the
uterosacral and pubocervicovesical ligaments. This has
made it possible for patients' lower urinary functions to
return more rapidly to their pre-operative states [2,5].
However, transient post-operative urinary dysfunction
involving urinary storage and evacuation function contin-
ues to be of concern [6].
In a study by Zaino and colleagues intra-operative compli-
cations were reported to occur as being 4.5% urinary tract
and 8.7% other organs (nervous, haemorrhage, intesti-
Table 1: Comparison of characteristics of Radical and Simple Hysterectomy groups of patients.
Characteristics RH group SH group p
Mean age 50.10 46.35 0.63
BMI 24.25 26.05 0.66
Parity 6 4 0.00
Blood loss (ml) 576 ml 416 ml 0.04
Mean operative time (min) 183. min 112. min 0.00
RH-Radical hysterectomy; SH-simple hyterectomy
Table 2: Postoperative urinary symptoms in RH and SH group of patients.
RH group SH group p
Positive U/C 1st visit 15% 11% 0.06
Positive U/C 2nd visit 31% 20% 0.00
Positive U/C 3rd visit 11% 9% NS
Urinary symptoms 1st visit 31% 20% 0.00
Urinary symptoms 2nd visit 40% 34% 0.07
Urinary symptoms 3rd visit 30% 33% NS
U/C-Urine Culture ; NS-Not significant; RH-Radical hysterectomy; SH-simple hyterectomy
Table 3: Comparison of urinary symptoms between patients undergoing RH but with or without pre-operative radiotherapy.
Urinary symptoms 
(Postoperatively)
RH group XRT + RH p
2 weeks, 1st visit 39% 44% 0.76
6 weeks, 2nd visit 36% 44% 0.64
14 weeks, 3rd visit 26% 44% 0.27
XRT-History of pre-operative radiotherapy; RH-Radical hysterectomyWorld Journal of Surgical Oncology 2005, 3:12 http://www.wjso.com/content/3/1/12
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nal) [7]. Ralph et al, reported a 6.6% rate of intra-opera-
tive urinary tract injuries during radical surgery for cervical
carcinoma [2]. In our study, we had no intestinal or blad-
der injuries occurring during radical hysterectomy. The
only ureteral injury (2%) occurred during "unroofing" of
the distal ureter and this was recognised and repaired
immediately.
Zaino et al, [7] reported a 20% risk of a post-operative uri-
nary tract fistula after radical surgery [7] and this contrasts
with a 4.4% risk of fistula in their series reported by Ralph
[2]. In our study, the only fistula occurred in a patient who
had received 5000 cGy radiotherapy before radical sur-
gery, and with continuous bladder drainage for 3 weeks
there was spontaneous healing of the fistula. The inci-
dence of urinary tract infection (UTI) in our series was
11% by 14 weeks after surgery and this was comparable to
that reported by Cardosi [8] but less than the figure of
20% documented by Abrao [9]. Also, Chen reported a
14% urinary tract infection rate following radical surgery
[10].
In our study, urinary tract dysfunctions that followed rad-
ical surgery were that 4% had an abnormal post-voiding
residual volume at the first post-operative visit. The first
voiding sensation at the third visit was 49% and stress uri-
nary incontinence was 17%. However, maximal capacity
remained abnormal in 65% of cases by 14 weeks after sur-
gery. Ralph et al reported that 67% of patients had impair-
ment or absence of bladder sensation after a RH [2]. In the
study from Chen et al, 84% of patients had an increased
first desire to void and maximal capacity in the post-oper-
ative period [10].
Urinary symptoms in our study occurred in 20% 2 weeks
after operation and which were higher in patients with
pre-operative radiotherapy (although not statistically sig-
nificant). Urinary symptoms remained high at the third
post-operative visit, although they declined in patients
who had undergone surgery alone.
In our study, the patients mean age; BMI, parity, operative
time, and blood loss were higher in those undergoing RH.
The mean age of our patients was higher than patients in
the study by Vervest et al, (mean was 45 years) [11]. Also
in this study [11] the patients BMI of 23.2 was lower than
that of the patients in our study. Cystometric parameters
and intra-operative and post-operative complications
showed little difference between patients having either
RH or SH. The small number of patients in our study
could have biased the results. However, in spite of the dif-
ferent gravidity and days of bladder drainage in the two
groups of patients, the overall complication rate is rela-
tively low in the RH patients. The data in this study
requires confirmation from future multicentric studies
with greater numbers of patients.
In recent years, several studies support the role of a gynae-
cological oncologist who is specifically trained in such
aspects of care and who can obtain optimal cytoreductive
surgery in patients with ovarian carcinoma [12,13]. There-
fore, it would seem that an experienced and appropriately
trained gynaecological oncologist might achieve a compli-
cation rate for patients undergoing radical hysterectomy
comparable with that reported by "general gynaecological
surgeons..
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